| Previous Close | 85.13 |
| Open | 85.50 |
| Bid | 85.45 x 800 |
| Ask | 85.80 x 1100 |
| Day's Range | 78.25 - 85.97 |
| 52 Week Range | 24.00 - 115.15 |
| Volume | 13,893,424 |
| Avg. Volume | 6,324,816 |
| Net Assets | 10.61B |
| NAV | 85.13 |
| PE Ratio (TTM) | N/A |
| Yield | 0.84% |
| YTD Daily Total Return | -8.73% |
| Beta (5Y Monthly) | 1.58 |
| Expense Ratio (net) | 0.75% |
| Inception Date | 2014-10-30 |
- Investor's Business Daily
Teladoc Stock Helps Fuel Big Gains In Hot Genome Play Near Buy Point
Teladoc stock is helping power Ark Genomic Revolution well ahead of the broader market this year, after a 178% run in 2020.
- Investopedia
Best Healthcare ETFs for Q2 2021
Healthcare exchange-traded funds (ETFs) invest in a basket of stocks of companies that provide medical services, develop medical equipment or drugs, offer medical insurance, or facilitate the provision of healthcare to patients.
- Investopedia
Best Biotech ETFs for Q2 2021
Biotech companies use or modify biological processes in order to create new pharmaceuticals or therapies. The biotech sector is particularly closely followed right now as a number of biotech companies around the world rush to develop potential vaccines for COVID-19.
© 2021 Verizon Media. All rights reserved.
